Universite de Liege
14 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
Recorded under 11 name spellings.
2
Ending by 2030
Sep 2027
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Jan 16, 2027The maintenance fee for Treatment of Hormonal Disorders of Growth (US 10,350,273) comes due Jan 16, 2027. Unpaid by Jul 16, 2027, it lapses early.
- 2 fees due Oct 7 to 28, 2027 · next Oct 7
Recent changes
- 1 of the patents on this record was granted since Aug 19, 2026
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,829,550 | Use of cyclodextrin for treatment and prevention of bronchial inflammatory diseases In force · From the USPTO record | In force | From the USPTO record | |
| US 8,009,918 | Visual background extractor In force · From the USPTO record | In force | From the USPTO record | |
| US 9,006,466 | Use of coumarin derivatives for the preparation of drugs for treating skin diseases In force · From the USPTO record | In force | From the USPTO record | |
| US 9,631,001 | Peptide Antagonists of the VASOPRESSIN-2 Receptor In force · High confidence | In force | High confidence | |
| US 10,174,374 | Detecting the brachyspina mutation In force · From the USPTO record | In force | From the USPTO record | |
| US 9,993,487 | Cyclodextrin and budesonide derivative compositions and methods In force · From the USPTO record | In force | From the USPTO record | |
| US 10,350,273 | Treatment of Hormonal Disorders of Growth In force · High confidence | In force | High confidence | |
| US 10,254,614 | Process of ultrasonic spray pyrolysis deposition of one or more electrochromic and/or electrolytic films on a substrate In force · From the USPTO record | In force | From the USPTO record | |
| US 10,633,633 | Mammalian Muscle-Derived Stem Cells In force · High confidence | In force | High confidence | |
| US 10,766,978 | Polyvinyl Alcohol and Method for Producing Same In force · High confidence | In force | High confidence |
Also on record, not counted in the 20: 14 patents in force now held by others · 63 lapsed for an unpaid fee · 12 ended at full term. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
10 pending · 10 abandoned · 53 no status recorded